Hangzhou Jiujifeng Network Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Hangzhou Jiujifeng Network Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include NAGSOFE. The owner is based in PilotFreeTradeZone.
-35,1stFloorBuilding1,No.299,ChutianRoad
XixingSt,BinjiangDist,HangzhouZhejiang
PilotFreeTradeZone 310000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Hangzhou Jiujifeng Network Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Hangzhou Jiujifeng Network Technology Co., Ltd. have?
Hangzhou Jiujifeng Network Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Hangzhou Jiujifeng Network Technology Co., Ltd. file in?
Hangzhou Jiujifeng Network Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 14 (Jewelry), Class 10 (Medical Apparatus). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.
What are Hangzhou Jiujifeng Network Technology Co., Ltd.'s most well-known trademarks?
Hangzhou Jiujifeng Network Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as NAGSOFE. These are among 1 currently registered trademark in the portfolio.
What is Hangzhou Jiujifeng Network Technology Co., Ltd.'s trademark registration success rate?
Hangzhou Jiujifeng Network Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.